HAGEN BRETT R (Chief Accounting Officer) sold 1.92K shares of KALARIS THERAPEUTICS, INC. on the open market
Open‑market sale worth $12.9K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/23/2026ACC: 0001193125-26-119707
Officer· Chief Accounting Officer
Since Jul 2020
+58.88K
Net shares
Net buyer
$12.9K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
60.80K acquired · 1.92K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.92K
Price / share
$6.72
Trade value
$12.87K
% of position
New position
3/20/2026
1.92K→0.00
Total
Net shares
−1.92K
Net value
-$12.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/20/2026 | S · Sale | −1.92K | $6.72 | $12.87K | New position | 1.92K | 0.00 |
| Total | −1.92K | -$12.87K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
60.80K shares
Shares
+60.80K
Strike price
6.81
Held after
60.80K
Exercisable
—
3/19/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock60.80K shares | 3/19/2026 | A · Award | +60.80K | 6.81 | — | 60.80K |